Intracellular innate immunity in gouty arthritis: Role of NALP3 inflammasome

Immunology and Cell Biology

Volumn 88, Issue 1, 2010, Pages 20-23

  Liu Bryan, Ru ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gout; Innate immunity; NALP3 inflammasome

Indexed keywords

COLCHICINE; CRYOPYRIN; INFLAMMASOME PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN DERIVATIVE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; UNCLASSIFIED DRUG; URATE; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN; URIC ACID;

ANTIGEN RECOGNITION; BINDING COMPETITION; CELL MATURATION; CELLULAR IMMUNITY; CRYSTAL; DRUG MECHANISM; GOUT; HUMAN; INNATE IMMUNITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; ANIMAL; IMMUNOLOGY; INFLAMMATION; INTRACELLULAR SPACE;

ANIMALS; ARTHRITIS, GOUTY; CARRIER PROTEINS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTRACELLULAR SPACE; URIC ACID;

EID: 74249112246     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.93     Document Type: Review

References (42)

1. Terkeltaub R. Pathogenesis and treatment of crystal-induced inflammation. In: Koopman E (ed). Arthritis and allied conditions, 15th edn. Lippincott Williams and Wilkins: W Philadelphia, 2004, 2357-2365.
2. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009; 21: 317-337.
3. Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 2001; 3: 36-41.
4. Rose DM, Liu-Bryan R. Innate immunity in triggering and resolution of acute gouty inflammation. Curr Rheumatol Rep 2006; 8: 209-214.
5. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med 2006; 84: 712-725.
6. Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 2006; 17: 6370-6378.
7. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005; 52: 2936-2946.
8. Gasse P, Riteau N, Charron S, Girre S, Fick L, Pé trilli V et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 2009; 179: 903-913.
9. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006; 116: 2262-2271.
10. Di Giovine FS, Malawista SE, Nuki G, Duff GW. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 1987; 138: 3213-3218.
11. Di Giovine FS, Symons JA, Duff GW. Kinetics of IL1 beta mRNA and protein accumulation in human mononuclear cells. Immunol Lett 1991; 29: 211-218.
12. Dinarello CA. Interleukin-1beta. Crit Care Med 2005; 33: S460-S462.
13. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002; 20: S1-13.
14. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14: 10-22.
15. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-411.
16. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-265.
17. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 301-305.
18. Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cellmediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004; 103: 2809-2815.
19. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20: 319-325.
20. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004; 364: 1779-1785.
21. Janssen R, Verhard E, Lankester A, Ten Cate R, van Dissel JT. Enhanced interleukin- 1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2004; 50: 3329-3333.
22. Martinon F, Pé trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241.
23. Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004; 14: 1929-1934.
24. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
25. Kanneganti TD, Ozören N, Body-MalapelM, Amer A, Park JH, Franchi L et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006; 440: 233-236.
26. Muruve DA, Pé trilli V, Zaiss AK, White LR, Clark SA, Ross PJ et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008; 452: 103-107.
27. Kool M, Pé trilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M et al. Cutting Edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008; 181: 3755-3759.
28. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008; 9: 847-856.
29. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453: 1122-1126.
30. Dostert C, Pé trilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674-677.
31. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008; 105: 9035-9040.
32. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008; 9: 857-865.
33. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006; 314: 1936-1938.
34. Pé trilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007; 14: 1583-1589.
35. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009; 459: 433-436.
36. Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005; 26: 447-454.
37. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1activation. Mol Cell 2007; 25: 713-724.
38. Mayor A, Martinon F, De Smedt T, Pé trilli V, Tschopp J. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol 2007; 8: 497-503.
39. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9: R28.
40. Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis 2009; 68: 1602-1608.
41. Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis 2009; 68: 1613-1617.
42. Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 1995; 96: 994-1002.